News

Clinical trial/study, heart failure, Sunshine Heart, C-Pulse System

Sunshine Heart Inc. announced the company's German Erlangen site for the OPTIONS-HF study has implanted its first patient with the C-Pulse(R) System for moderate to severe heart failure. 

ACC 2015 late breaking trials

The latest data on TAVR, transcatheter mitral valve repair, the use of CT to evaluate chest pain, first report on the use of TAVR embolic protection, denervation for pulmonary arterial...

CVRx, Barostim neo Legacy System, pacemaker, hypertension, FDA, HDE

The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx Inc. Barostim neo Legacy System.

radiation therapy, breast cancer, breath hold, heart, clinical study

Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after...

Bellerophon Therapeutics LLC announced that it has completed enrollment of its PRESERVATION I clinical trial of Bioabsorbable Cardiac Matrix (BCM), an investigational implantable medical device...

Clinical trial, MRI system, Peripheral Artery Disease, Renal Artery Stenosis

Non-contrast enhanced MR angiography (MRA) techniques have attracted interest in the medical community for diagnosing renal artery stenosis, as it eliminates the need for contrast agents used with...

Our daily diet may help lower bad cholesterol, in turn reducing risk for heart disease, according to health researchers in the Jan. 7 edition of the Journal of the American Heart Association...

Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment...

Gore Medical, Gore Viabahn Endoprosthesis, CE Mark, stent grafts

W. L. Gore & Associates Inc. announced that the Gore Viabahn Endoprosthesis has received CE Mark approval to improve blood flow in symptomatic obstruction of peripheral veins,...

CardioKinetix, Parachute, PARACHUTE III, heart failure, clinical trial

CardioKinetix Inc. announced results of a pooled analysis study of the catheter-based Parachute ventricular partitioning device. Twelve-month clinical data from PARACHUTE III, a study of 100...

Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-sponsored REPLACE Registry...

Discussions regarding late-breaking cardiovascular clinical trials among leading medical scientists are placing considerable emphasis on individualized patient care, particularly in the area of...

A study that identifies new heart attack risk factors and supports the use of a blood test for detection in patients will be published in the AACE (American Association of Clinical...

InspireMD, MGuard, CGuard, drug-eluting stent, MASTER II, CARENET, trials

InspireMD, Inc. announced results from two important clinical trials. Thirty-day results from the MASTER II trial, which enrolled 310 of a planned 1,114 patients were presented at a major...

REPRISE II trial, Lotus Valve System, Boston Scientific, one year data

New data from the Boston Scientific clinical trial program of the Lotus Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic...

Patients who were obese before developing heart failure lived longer than normal weight patients with the same condition according to a new study in the Journal of the American College of...

bioresorbable stents

Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely expected to overtake metallic stents in the coming years if the data trend...

stents, bioresorbable, clinical trial, clinical study

Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold. 

Tiara Transcatheter Mitral Valve, neovasc

Now that transcatheter aortic valve replacement (TAVR) is rapidly becoming an established treatment option, cardiology has shifted focus toward the next major frontier in interventional structural...

The American College of Cardiology and the American Heart Association released clinical data standards for cardiovascular and endpoints in clinical trials.